- Home
- SNTG vs VRAX Comparison
SNTG vs VRAX Comparison
Compare SNTG & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- VRAX
- Stock Information
- Founded
- SNTG 2009
- VRAX 2013
- Country
- SNTG China
- VRAX United Kingdom
- Employees
- SNTG N/A
- VRAX N/A
- Industry
- SNTG Finance: Consumer Services
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SNTG Finance
- VRAX Health Care
- Exchange
- SNTG Nasdaq
- VRAX Nasdaq
- Market Cap
- SNTG 4.8M
- VRAX 4.7M
- IPO Year
- SNTG 2021
- VRAX 2022
- Fundamental
- Price
- SNTG $1.84
- VRAX $0.81
- Analyst Decision
- SNTG
- VRAX Strong Buy
- Analyst Count
- SNTG 0
- VRAX 1
- Target Price
- SNTG N/A
- VRAX $3.00
- AVG Volume (30 Days)
- SNTG 6.5K
- VRAX 37.2K
- Earning Date
- SNTG 07-07-2025
- VRAX 02-05-2025
- Dividend Yield
- SNTG N/A
- VRAX N/A
- EPS Growth
- SNTG N/A
- VRAX N/A
- EPS
- SNTG N/A
- VRAX N/A
- Revenue
- SNTG $107,507.00
- VRAX $84,872.00
- Revenue This Year
- SNTG N/A
- VRAX $5,169.18
- Revenue Next Year
- SNTG N/A
- VRAX $66.97
- P/E Ratio
- SNTG N/A
- VRAX N/A
- Revenue Growth
- SNTG N/A
- VRAX 7.03
- 52 Week Low
- SNTG $1.43
- VRAX $0.75
- 52 Week High
- SNTG $3.97
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- SNTG 54.53
- VRAX 31.75
- Support Level
- SNTG $1.67
- VRAX $0.75
- Resistance Level
- SNTG $1.92
- VRAX $0.85
- Average True Range (ATR)
- SNTG 0.09
- VRAX 0.07
- MACD
- SNTG 0.01
- VRAX -0.01
- Stochastic Oscillator
- SNTG 62.96
- VRAX 6.57
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.